Company intelligence / Profile preview
Alaxia
Lyon, Auvergne-Rhône-Alpes / Rhone Alpes, Francealaxia-pharma.eu ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Other
01
Overview
ALX‑009, Alaxia’s lead compound, has completed or nearly completed Phase I trials in cystic fibrosis and bronchiectasis. It demonstrated promising antimicrobial activity against multi-resistant Gram-negative bacteria. The company also explored its potential virucidal effect against SARS-CoV‑2 in collaboration with academic partners. Patient enrollment for Phase IIa was planned but no published results from later phases are available as of May 2025.
- Therapeutic areas
- PulmonologyInfectious Diseases
- Modalities
- Small moleculesAntimicrobial agents
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
iABC consortium under the ND4BB program within IMI (Innovative Medicines Initiative), a public-private partnership between EU & pharma industryUniversity of Padova Department of Molecular Medicine, BSL3 lab collaboration on SARS-CoV‑2 researchSupported by French public bank Bpifrance & Cystic Fibrosis Foundation
Beyond the preview
Go deeper on Alaxia.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Alaxia.